Charles River Laboratories Net Income 2010-2025 | CRL

Charles River Laboratories annual/quarterly net income history and growth rate from 2010 to 2025. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Charles River Laboratories net income for the quarter ending March 31, 2025 was $0.025B, a 65.09% decline year-over-year.
  • Charles River Laboratories net income for the twelve months ending March 31, 2025 was $-0.037B, a 108.37% decline year-over-year.
  • Charles River Laboratories annual net income for 2024 was $0.01B, a 97.83% decline from 2023.
  • Charles River Laboratories annual net income for 2023 was $0.475B, a 2.39% decline from 2022.
  • Charles River Laboratories annual net income for 2022 was $0.486B, a 24.36% increase from 2021.
Charles River Laboratories Annual Net Income
(Millions of US $)
2024 $10
2023 $475
2022 $486
2021 $391
2020 $364
2019 $252
2018 $226
2017 $123
2016 $155
2015 $149
2014 $127
2013 $103
2012 $97
2011 $110
2010 $-337
2009 $114
Charles River Laboratories Quarterly Net Income
(Millions of US $)
2025-03-31 $25
2024-12-31 $-225
2024-09-30 $69
2024-06-30 $94
2024-03-31 $73
2023-12-31 $187
2023-09-30 $87
2023-06-30 $97
2023-03-31 $103
2022-12-31 $187
2022-09-30 $96
2022-06-30 $109
2022-03-31 $93
2021-12-31 $138
2021-09-30 $103
2021-06-30 $88
2021-03-31 $62
2020-12-31 $143
2020-09-30 $103
2020-06-30 $67
2020-03-31 $51
2019-12-31 $80
2019-09-30 $73
2019-06-30 $44
2019-03-31 $55
2018-12-31 $60
2018-09-30 $60
2018-06-30 $54
2018-03-31 $53
2017-12-31 $-30
2017-09-30 $52
2017-06-30 $54
2017-03-31 $47
2016-12-31 $45
2016-09-30 $38
2016-06-30 $35
2016-03-31 $37
2015-12-31 $32
2015-09-30 $37
2015-06-30 $49
2015-03-31 $32
2014-12-31 $27
2014-09-30 $32
2014-06-30 $35
2014-03-31 $32
2013-12-31 $19
2013-09-30 $31
2013-06-30 $27
2013-03-31 $26
2012-12-31 $18
2012-09-30 $22
2012-06-30 $30
2012-03-31 $26
2011-12-31 $27
2011-09-30 $19
2011-06-30 $32
2011-03-31 $31
2010-12-31 $-344
2010-09-30 $-25
2010-06-30 $14
2010-03-31 $17
2009-12-31 $18
2009-09-30 $37
2009-06-30 $34
2009-03-31 $25
Sector Industry Market Cap Revenue
Medical Medical Services $7.460B $4.050B
Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research and drug development efforts. The company has a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP. This helps support its clients from target identification through non-clinical development. Charles River also provides a line of products and services to support clients' manufacturing activities. Utilizing the company's broad portfolio of products and services, clients can create a more flexible drug development model, aiming cost reduction, productivity enhancement and increase in speed to market. Charles River currently has three reporting segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA) and Manufacturing Support.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $146.784B 27.53
Elevance Health (ELV) United States $87.260B 11.26
CVS Health (CVS) United States $83.934B 10.43
Cencora (COR) United States $57.186B 19.90
Natera (NTRA) United States $22.441B 0.00
DiDi Global (DIDIY) China $22.121B 23.50
BioMerieux (BMXMF) France $16.861B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.895B 0.00
Solventum (SOLV) United States $12.853B 13.61
ICON (ICLR) Ireland $11.879B 11.04
CochLear (CHEOY) Australia $11.671B 0.00
Revvity (RVTY) United States $11.280B 19.41
Doximity (DOCS) United States $10.697B 49.52
Viatris (VTRS) United States $10.669B 3.67
Avantor (AVTR) United States $9.227B 13.41
HealthEquity (HQY) United States $8.993B 39.39
Medpace Holdings (MEDP) United States $8.737B 23.21
Sonic Healthcare (SKHHY) Australia $8.503B 0.00
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.400B 25.92
BrightSpring Health Services (BTSG) United States $3.797B 34.84
Sotera Health (SHC) United States $3.335B 18.95
Alignment Healthcare (ALHC) United States $2.983B 0.00
Surgery Partners (SGRY) United States $2.961B 38.50
Concentras Parent (CON) United States $2.793B 16.14
Organon (OGN) United States $2.618B 2.78
Ardent Health (ARDT) United States $1.938B 8.26
GeneDx Holdings (WGS) United States $1.894B 72.93
Premier (PINC) United States $1.855B 14.08
Progyny (PGNY) United States $1.847B 40.66
PACS (PACS) United States $1.614B 0.00
GoodRx Holdings (GDRX) United States $1.600B 32.00
Teladoc Health (TDOC) United States $1.258B 0.00
Pediatrix Medical (MD) United States $1.224B 9.31
Establishment Labs Holdings (ESTA) $1.073B 0.00
CareDx (CDNA) United States $1.048B 16.37
Ryman Healthcare (RYHTY) New Zealand $1.011B 0.00
Agilon Health (AGL) United States $0.907B 0.00
AMN Healthcare Services Inc (AMN) United States $0.828B 7.75
QDM (QDMI) Hong Kong, SAR China $0.763B 0.00
Nutex Health (NUTX) United States $0.694B 10.51
Embecta (EMBC) United States $0.587B 3.95
LifeMD (LFMD) United States $0.577B 0.00
Enhabit (EHAB) United States $0.505B 41.54
InnovAge Holding (INNV) United States $0.498B 0.00
Auna S.A (AUNA) Luxembourg $0.469B 10.57
Sonida Senior Living (SNDA) United States $0.467B 0.00
SBC Medicals (SBC) United States $0.464B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.423B 0.00
Performant Healthcare (PHLT) United States $0.257B 0.00
Oncology Institute (TOI) United States $0.236B 0.00
Beauty Health (SKIN) United States $0.197B 0.00
DocGo (DCGO) United States $0.154B 25.17
KindlyMD (KDLY) United States $0.150B 0.00
Pheton Holdings (PTHL) China $0.111B 0.00
KindlyMD (NAKA) United States $0.102B 0.00
So-Young (SY) China $0.095B 0.00
Basel Medical Group (BMGL) Singapore $0.087B 0.00
OncoCyte (OCX) United States $0.077B 0.00
Sera Prognostics (SERA) United States $0.067B 0.00
Ascend Wellness Holdings (AAWH) United States $0.063B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.055B 0.00
ModivCare (MODV) United States $0.048B 0.00
Biodesix (BDSX) United States $0.044B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.029B 0.00
Intelligent Bio Solutions (INBS) United States $0.013B 0.00
SeaStar Medical Holding (ICU) United States $0.013B 0.00
Co-Diagnostics (CODX) United States $0.010B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
INVO Fertility (IVF) United States $0.003B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00